Clinical Trial Results TV
Health economics QOL: 10 submissions

| Page 1 |

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Cannon and Dr. Gibson discuss the COGENT Trial and the limitations of observational data
Dr. Christopher P. Cannon, Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. David Cohen and Dr. C. Michael Gibson discuss the TRITON-TIMI 38 Economic Substudy
Dr. David Cohen, MD, Dr. C. Michael Gibson, MD

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Gibson and Dr. Brindis Compare the Benefits of Randomized Trials and Registries at TCT 2009
Dr. C. Michael Gibson, MD, Dr. Ralph Brindis

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Harrington and Dr. Gibson discuss dronedarone, personalized medicine, and authorship issues concerning academic and
Dr. Robert Harrington, Dr. C. Michael Gibson

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Cohen and Dr. Gibson discuss the one year results from the SYNTAX trial
Dr. David J. Cohen, Dr. C. Michael Gibson

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Mark Turco and Dr. C. Michael Gibson discuss comparative effectiveness research
Dr. Mark Turco, Dr. C. Michael Gibson

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Cohen and Dr. Gibson Provide an Update on the Economics of Drug Eluting Stents: Insights from the Medicare Database
Dr. David J. Cohen, Dr. C. Michael Gibson

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Pinto and Dr. Gibson Discuss Cost Effectiveness for Ischemic and Bleeding Events
Dr. Duane Pinto, Dr. C. Michael Gibson

1 Star 2 Star 3 Star 4 Star 5 Star
Pay For Performance: What Does it Mean, What will be its Impact in CV Care by James Hoekstra, MD
Dr. James Hoekstra

1 Star 2 Star 3 Star 4 Star 5 Star
Dr. Bill Boden and Dr. C. Michael Gibson discuss the results of the COURAGE trial
Dr. C. Michael Gibson, Dr. William Boden